Showing results (1171-1180 of 1,350) with videos related to
Sort By:
Pageof 135
Epilepsia|June 18, 2022
Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progressJuliet K Knowles, Ingo Helbig, Cameron S Metcalf, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Classification models distinguish functional and trafficking effects of KCNQ1 variants to enhance variant interpretationAna C Chang-Gonzalez, Eric W Bell, Carlos G Vanoye, et al.International Journal of Environmental Research and Public Health|May 27, 2026
Cultural, Societal, and Behavioral Contributors to Delays in Seeking Care for Postmenopausal Bleeding Among Disaggregated Populations of Black WomenMaurice J Chery, Wilmar B Mondestin, LaShae D Rolle, et al.Circulation|May 9, 2002
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointesPing Yang, Hideaki Kanki, Benoit Drolet, et al.Circulation. Genomic and Precision Medicine|November 7, 2025
Functional Profiling of <i>KCNE1</i> Variants Informs Population Carrier Frequency of Jervell and Lange-Nielsen Syndrome Type 2Carlos G Vanoye, Reshma R Desai, Jordan D John, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group BDavid M Dilts, Alan B Sandler, Matthew Baker, et al.Stem Cell Reports|March 11, 2022
Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controlsDina Simkin, Vasileios Papakis, Bernabe I Bustos, et al.Blood|April 27, 2011
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemiaMarc Buyse, Pierre Squifflet, Beverly J Lange, et al.Biorxiv : the Preprint Server for Biology|April 16, 2025
Functional profiling of <i>KCNE1</i> variants informs population carrier frequency of Jervell and Lange-Nielsen syndrome type 2Carlos G Vanoye, Reshma R Desai, Jordan D John, et al.Nuclear Medicine Communications|January 28, 2016
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastomaSally L George, Nadia Falzone, Sarah Chittenden, et al.Pageof 135